EUVIMEDObjevte EUVIMED
Crossref

Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease

Gloria F Gerber iD, Sacha Choupa iD, Amy Luo, Vinal Menon iD, Nadine Shehata iD, Jayla Scott iD, Macy L E Gatti iD, Michael B Streiff iD, Rakhi P Naik iD, Kevin Kuo iD, A Kinga Malinowski iD, Lydia H Pecker iD

British Journal of Haematology · 2026-11-16

DOI: 10.1111/bjh.70943 ↗

At a glance

Journal article in British Journal of Haematology, published online on 2026-11-16. Written by Gloria F Gerber and 11 co-authors. Institution: Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 48 references. Funded by: Hemostasis and Thrombosis Research Society by an educational grant from Takeda Pharmaceuticals U.S.A., Foundation for Women and Girls with Blood Disorders, NHLBI NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Sickle cell disease (SCD) is a thrombophilia exacerbated by pregnancy. However, there is not strong evidence for thromboprophylaxis, perhaps because most data addressing pregnancy‐related thrombosis in SCD is limited by derivation from administrative datasets. We studied venous thromboembolism (VTE) in a retrospective cohort of pregnant people with SCD who delivered singleton pregnancies at two academic centres between 1990 and 2021. Among 289 pregnancies to 197 SCD subjects, 6% had VTE. We compared characteristics of the first study pregnancy in which a VTE occurred (cases) to the first study pregnancy in subjects without pregnancy‐related VTE (controls). Preconception complications associated with VTE were history of VTE (cases: 33% [ n = 5/15] vs. controls: 4% [ n = 7/182], p < 0.001), acute chest syndrome (ACS) (80% [ n = 12/15] vs. 37% [ n = 68/182], p = 0.001) and acute care for vaso‐occlusive crisis (VOC) in the year before pregnancy (80% [ n = 12/15] vs. 43% [ n = 70/182], p = 0.006). Prenatal complications associated with VTE were ACS (47% [ n = 7/15] vs. 10% [ n = 19/182], p < 0.001) and VOC (93% [ n = 14/15] vs. 65% [ n = 119/182], p = 0.026). Fetal outcomes associated with VTE included gestational age at delivery (median [IQR] 37.0 [34.0–38.1] weeks vs. 38.3 [36.9–39.3], p = 0.004). Studies are needed to establish interventions that attenuate VTE risk and define prophylactic anti‐coagulation parameters for this high‐risk population.

Subjects

Author keywords

deep vein thrombosispregnancypulmonary embolismsickle cell diseasevenous thromboembolism

Authors and institutions

  • Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Meharry Medical College, School of Medicine, Nashville, Tennessee, USA.
  • Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Haematology, Department of Medicine, University Health Network, Toronto, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

ORCID profiles: Gloria F Gerber, Sacha Choupa, Vinal Menon, Nadine Shehata, Jayla Scott, Macy L E Gatti, Michael B Streiff, Rakhi P Naik, Kevin Kuo, A Kinga Malinowski, Lydia H Pecker

Funding

  • Hemostasis and Thrombosis Research Society by an educational grant from Takeda Pharmaceuticals U.S.A.
  • Foundation for Women and Girls with Blood Disorders
  • NHLBI NIH HHS
  • Federal Drug Administration, Office of Women's Health/Center for Excellence in Regulatory Science and Innovation
  • NIMH NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Mental Health

Cite

APA

Gerber, G. F., Choupa, S., Luo, A., Menon, V., Shehata, N., Scott, J., Gatti, M. L. E., Streiff, M. B., Naik, R. P., Kuo, K., Malinowski, A. K., & Pecker, L. H. (2026). Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease. British Journal of Haematology. https://doi.org/10.1111/bjh.70943

Vancouver

Gerber GF, Choupa S, Luo A, Menon V, Shehata N, Scott J, et al. Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease. British Journal of Haematology. 2026. doi:10.1111/bjh.70943

BibTeX
@article{Gerber2026,
  author = {Gerber, Gloria F and Choupa, Sacha and Luo, Amy and Menon, Vinal and Shehata, Nadine and Scott, Jayla and Gatti, Macy L E and Streiff, Michael B and Naik, Rakhi P and Kuo, Kevin and Malinowski, A Kinga and Pecker, Lydia H},
  title = {Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70943}
}
Start for free →